Odyssey Group International Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion
IRVINE, CA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical company...
IRVINE, CA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical company...
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Sept. 22, 2021 (GLOBE NEWSWIRE)...
UBN RELIEF™ UBN RELIEF™ is clinically proven to provide some relief from symptoms often related to migraine headaches. LAS VEGAS,...
BREXAFEMME® (ibrexafungerp tablets) Product Image #1 BREXAFEMME® (ibrexafungerp tablets) Package Image #2 BREXAFEMME® (ibrexafungerp tablets) Product Logo SCYNEXIS Logo SCYNEXIS...
WALTHAM, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology...
FLORHAM PARK, N.J., Sept. 22, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel...
Agreement To Advance Healthcare Diagnostic TechnologiesJackson Center, Pennsylvania--(Newsfile Corp. - September 22, 2021) - Halberd Corp. (OTC Pink: HALB) and...
RELX closed-pod products to be offered across 180 Smoke's retail, e-commerce and wholesale channelsVaughan, Ontario--(Newsfile Corp. - September 22, 2021)...
Toronto, Ontario--(Newsfile Corp. - September 22, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
Company Continues to Expand Its Scientific Expertise with Noted Expert in Utilizing Ketamine for Treatment Resistant DepressionVANCOUVER, BC / ACCESSWIRE...
STOCKHOLM, SE / ACCESSWIRE / September 22, 2021 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical...